A detailed history of New Century Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, New Century Financial Group, LLC holds 3,057 shares of LLY stock, worth $2.29 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
3,057
Previous 2,185 39.91%
Holding current value
$2.29 Million
Previous $1.98 Billion 36.93%
% of portfolio
0.99%
Previous 0.84%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$772.14 - $960.02 $673,306 - $837,137
872 Added 39.91%
3,057 $2.71 Billion
Q2 2024

Aug 27, 2024

BUY
$724.87 - $909.04 $144,249 - $180,898
199 Added 10.02%
2,185 $1.98 Billion
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $461,916 - $617,978
780 Added 64.68%
1,986 $1.55 Billion
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $633,379 - $746,670
1,206 New
1,206 $703 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track New Century Financial Group, LLC Portfolio

Follow New Century Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Century Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Century Financial Group, LLC with notifications on news.